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The phasor-FLIM fingerprints reveal 
shifts from OXPHOS to enhanced 
glycolysis in Huntington Disease
Sara Sameni1,2, Adeela Syed3, J. Lawrence Marsh3 & Michelle A. Digman1,2,3,4
Huntington disease (HD) is an autosomal neurodegenerative disorder caused by the expansion of 
Polyglutamine (polyQ) in exon 1 of the Huntingtin protein. Glutamine repeats below 36 are considered 
normal while repeats above 40 lead to HD. Impairment in energy metabolism is a common trend in 
Huntington pathogenesis; however, this effect is not fully understood. Here, we used the phasor 
approach and Fluorescence Lifetime Imaging Microscopy (FLIM) to measure changes between free and 
bound fractions of NADH as a indirect measure of metabolic alteration in living cells. Using Phasor-
FLIM, pixel maps of metabolic alteration in HEK293 cell lines and in transgenic Drosophila expressing 
expanded and unexpanded polyQ HTT exon1 in the eye disc were developed. We found a significant 
shift towards increased free NADH, indicating an increased glycolytic state for cells and tissues 
expressing the expanded polyQ compared to unexpanded control. In the nucleus, a further lifetime 
shift occurs towards higher free NADH suggesting a possible synergism between metabolic dysfunction 
and transcriptional regulation. Our results indicate that metabolic dysfunction in HD shifts to increased 
glycolysis leading to oxidative stress and cell death. This powerful label free method can be used to 
screen native HD tissue samples and for potential drug screening.
The mechanisms underlying neurodegeneration in Huntington Disease(HD) are unknown, but compelling evi-
dence suggests that mitochondrial defects may play a central role1. Mitochondria dysfunction has been linked to 
a range of disease and health problems such as cancer and neurodegenerative diseases2. Thus early detection of 
mitochondria anomalies and metabolic dysfunction might help contribute to effective diagnosis and subsequent 
treatment.
Previous studies show that HD onset can be identified from disturbed glucose metabolism. Glucose metabo-
lism in asymptomatic HD carriers reveals significant hypometabolism and a 2–3% reduction in caudate glucose 
metabolism per year. This implies there is a significant reduction of glucose metabolism occurring during the 
onset of the disease, and the measurement of striatal metabolism receptor binding would be a good marker for 
the diagnostic of the progression of the disease3,4. Yet other studies report that lactate produced by glucose uptake 
is enhanced in HD brain tissue of transgenic and 3-nitropropionic acid-treated mouse models for HD5. Olah 
and coworkers measured high glycolytic flux in the posterior region of HD brains by measuring mitochondrial 
complex activities, NADH absorption, pyruvate formation and lactate production5. In their experiment-based 
mathematical model, the authors calculate the increased flux through the glycolytic pathway where they revealed 
that the increased energy metabolism enhances the rate of glycolytic flux in comparison to the control. However, 
the hypothesis that the ATP production through oxidative phosphorylation (OXPHOS) indicates a shift metab-
olism to glycolysis in HD is not yet clear6.
Chance et al., in the 1950s, pioneered the measurement and quantification of tissue and cellular metabolic 
states, and since then many studies followed7–9. These investigations were based on florescence emission of 
reduced nicotinamide adenine dinucleotide (NADH) as an endogenous florescent biomarker. NADH is the prin-
cipal electron acceptor in glycolysis and electron donor in oxidative phosphorylation10. While NADH fluoresces, 
its oxidized form (NAD+ ) does not, and research has been focused on measuring the fraction of intracellular free 
and bound forms (to enzymes) of NADH11. Given that the fluorescence lifetime of NADH shifts in the bound 
versus free state, NADH autofluorescence has been used as a biomarker for oxidative stress in alpha-synuclein 
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aggregation, metabolic changes in Wnt signaling in colon cancer was characterized using NADH-FLIM12–14. Since 
FLIM is independent of concentration, the lifetimes of free and bound forms of NADH are unbiased from endog-
enous levels produced in living cells. Also the lifetime of free NADH is shorter (~0.4 ns), indicating more glyc-
olysis, compared to the fully bound form (3.2 ns–3.4 ns), indicating more oxidative phosphorylation. Thus their 
fractional contributions can be a measure of oxidative stress or cellular homeostasis2,12,15.
In this work, we have used the phasor approach to FLIM to measure fraction of free to bound NADH as a way 
to map the metabolic alteration in cells transfected with expanded and unexpanded polyQ HTT exon 1. Image 
segmentation to isolate the cytoplasm was also done and further characterized a lifetime shift towards the free 
fractional component of NADH in the cell nucleus. In addition we have performed FLIM in the late third instar 
eye discs of a Drosophila model of Huntington disease16. During this late third instar stage (approximately 3–4.5 
days post fertilization) eye imaginal discs complete development and photoreceptor neurons are born17,18.
Our results indicate that, in the presence of the expanded Huntingtin repeat, fingerprints of the phasor distri-
butions shift towards an increased free NADH lifetime in the nucleus. It has been shown that NADH interaction 
with regulatory proteins such as CtBP and Sirtuins influences their transcriptional activity19,20. Moreover, while 
NAD(P)H is shown to enhance heterodimerisation and DNA binding to transcription factors, its oxidized form, 
NAD(P), inhibits such activities20. Thus we hypothesize that such an increase in nuclear NADH leads to transcrip-
tional dysregulation. Further, we observed an increase in the ratio free/bound NADH (shift toward anaerobic 
glycolysis) in the cytosolic region in the presence of the expanded Huntingtin repeat. This is in correlation with 
previous studies that showed hypoxic conditions by a shortening of NADH fluorescence lifetime (i.e. more free 
NADH) in cells21, tissue22 and organs in vitro23 and in vivo24.
Results
Increase free NADH in HEK 293 cell lines expressing the expanded polyQ Exon1. Using HEK 293 
cells transiently transfected with exon 1 of the human Huntingtin protein with either unexpanded or expanded 
polyQ, we show that the relative ratio of free to bound NADH increases on average when cells are challenged with 
expanded polyQ HTT exon1. This increase in the free/bound ratio indicates that cells expressing the expanded 
HTT repeat show a shift of ATP production from OXPHOS to glycolytic metabolism. We have used the FLIM 
phasor approach to in which the fluorescence decay at each pixel is transformed into a single point in the phasor 
plot, defined in the materials and methods section and in Supplemental Figure S1. In the phasor plot, the s(ω ) and 
g(ω ) coordinates for every pixel of the image, Fourier sine vs. the Fourier cosine, are plotted on the y and x axis 
where the x coordinate spans from 0 to 1 and the y spans from 0 to 0.5. Thus the g coordinate is more sensitive to 
the ratio of free to bound NADH as shown in supplemental (Figure S2)25,26.
Figure 1 shows the simultaneous intensity of EGFP, excited directly at 488 nm, and NADH autofluores-
cence, excited via two-photon excitation at 740 nm, for HEK 293 expressing EGFP alone, 25QHTT-GFP and 
97QHTT-GFP. The color of the lifetime maps (Fig. 1C) corresponds to the fluorescence lifetime distribution 
along the phasor plot shown in panel D for each of the 3 conditions. We applied image segmentation to isolate 
the nuclear compartment from the cytoplasmic pool as is shown in supplement S3 to further quantify the aver-
age phasor coordinates corresponding to the g and s axis on the phasor plot. Our results indicate a significant 
shift in NADH lifetime, indicating a transition from the NADH bound to the NADH free form, in cells express-
ing the expanded Httex1p97Q-EGFP protein compared to the Httex1p25Q expressing cells as shown in Fig. 2A 
(P = 1.02 × 10−6).
We identified two distinct populations (Fig. 2) in the nuclear and cytoplasmic phasors corresponding to the 
Httex1p25Q-EGFP and Httex1p97Q-EGFP variants in HEK 293 cells. To further confirm our data and to ensure 
that changing the fluorescent protein does not perturb NADH readings we have performed experiment in 15 more 
animals (total of 66 ROIs) tagged with Kaede (Figure S4). The applied image segmentation for the nuclear compart-
ment shows a decreased nuclear activity in cells expressing the expanded form of the HTT protein. In both expanded 
and unexpanded HTT protein expressing cells, the nucleus is characterized by high amount of free NADH. This 
is consistent with the results published by Wright et al.12 which shows reduced nuclear activity characterized by 
shorter lifetime (more free NADH) for undifferentiated or early differentiating cells and more bound NADH due 
to increased nuclear activity in differentiating cells. In the expanded HTT expressing cells there is a significant 
increased fraction of free NADH indicating a lower nuclear activity (p = 0.0024) (Fig. 2B). No differences were 
observed for the control experiments of the cell cytoplasm and nucleus in the EGFP expressing cells compared to the 
wild type, Httex1p25Q-EGFP with p value higher than 0.05 (p = 0.206 and p = 0.209 accordingly).
Transgenic Drosophila results. To further test our results in vivo, we have examined the eye discs of a 
transgenic Drosophila model of HD. Drosophila is an excellent source for modeling neurodegenerative disease 
as it contains fully functional nervous system with separate specialized functions including vision, olfaction, 
learning and memory16. The most common method for generating restricted transgene expression in Drosophila 
is based on the yeast GAL4 protein and its target upstream activating upstream sequence (UAS) system27.
The eye develops from the eye antennal disc. The disc arises from about 20 cells of the optic primordium in 
the embryonic blastoderm28. By the third instar, the eye disc forms approximately 20,000 cells 28. Barbaro et al. 
earlier showed temporal gradients of neurons expressing HTT transgenes in Drosophila eye discs. Cells begin to 
differentiate into neurons in the eye disc as a wave of differentiation passes from posterior to anterior during L3 
(defined by the morphogenetic furrow). As the wave moves toward the anterior in an array of cells ordered in 
rows forward, each row of cells from the leading edge of the furrow toward the posterior has been expressing the 
HTT transgene 2 h longer than the row in front of it29. We have selected to analyze the posterior part of the eye 
disc where the oldest cells expressing the transgenes (120Q, 96Q or 25Q) reside.
Figure 3 shows tiled image of expanded 90ex1 96Q-GFP. The Drosophila eye disc excited at 488 nm in respect to 
the whole eye disc (bright field image merged with FITC) is depicted here. The posterior region expressing the 
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HTTexon1p 96Q-GFP was selected and the distributions of lifetimes were mapped. Similar to what we have 
observed in the HEK 293 cells, a shift toward shorter lifetime in cells expressing HTT 96Q-GFP of the live eye 
disc was detected. To ensure that the expression of GFP did not perturb the metabolism in this model, we tested 
the unexpanded versus the expanded HTT with no fluorophore tag (Unexpanded 90ex1 25Q vs. expanded 90ex1 120Q 
expressing flies). The images here are obtained from the most posterior part of each eye disc that is associated 
with either 25Q or 120Q expressions. As shown in Fig. 4, the three representative tissue ROI of the 25Q 
populations are characterized with longer lifetime associated with decreased ratios of free to bound NADH similar 
to what was observed in the HEK 293 cell line (white/aqua color) with unexpanded transfection; while the 
expanded models (i.e. 120 Q) are shifted towards the shorter lifetime with increased ratio of free to bound NADH 
(pink/red color).
Figure 5 shows the scatter plot of phasor lifetimes averages for the eye discs expressing the unlabeled unex-
panded (blue) and expanded HTT protein (red). The analysis of the phasor distribution in this case is performed 
by cluster identification as described in ref. 30. The clusters refer to all the pixels selected in the ROI and are the 
average coordinates lifetime for each ROI of the three eye discs.
The Student t test was done to compare the 25Q population and 120Q population in terms of g values. Our 
result indicates that these two populations are statistically significantly different (p-value of 0.034). In addition, 
the 25Q group shows significantly longer lifetime compared to 96Q group (p-value 0.023).
No difference was observed in control group (Venus with no HTT) compared to 25Q with the p-value 
> 0.05(P = 0.14) (Fig. 6).
Discussion
Energy production deficiency contributes to the progression of HD and a common side effect is weight loss in HD 
patients31. The dysfunction in energy metabolism, in particular mitochondrial perturbation, is a common trend 
in Huntington pathogenesis studies in human and animal models32. It has been postulated that HTT perturbs the 
activation of SIRT 3 leading to a decrease in concentration of NAD and PGC-1α (a transcriptional coactivator 
controlling mitochondrial biogenesis and function)33. Given that SIRT 3 acetylates the flavoprotein (Fp) subunit 
Figure 1. Panel A shows confocal images obtained using the 488 nm laser to excite EGFP directly. In panel 
B NADH emission was obtained with 740 nm two-photon excitation. NADH is detected with a blue filter 
(442/46 nm) in one channel and EGFP emission with a green filter (520/35 nm). Nuclei of the cells are shown 
with dashed red circle. Panel C represents lifetime maps of NADH colored according to the color scale in 
the phasor plot in panels D. When cells express the expanded Htt 97Qp, there is a significant shift toward the 
shorter lifetime indicating a higher glycolytic state. Panel D also shows the phasor plot for each representative 
cell. The phasor histogram of the cell transfected with 97Q is shifted to the direction of free NADH. Scale bar on 
the image is 10 μ m.
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of complex II, the loss of SIRT 3 activity in HD leads to a reduced binding of complex II with the Fp thereby dys-
regulating mitochondrial function33.
Alterations of metabolism have recently gained traction in identifying the mechanism by which the metabolic 
pathway is affected. Insight into metabolic requirements in distinct populations of striatal versus cortical neuron 
is provided by Gorarne and co-workers34. They showed that early subtle defects in glycolysis were found in striatal 
neurons using PET in living patients. However, contradicting results were recently reported by Nambron et al. 
that revealed metabolic carbohydrate, lipid and protein metabolites as wells as hormones related to energy 
metabolism screening in HD patients resulted in no significant changes compared to the control subjects35. These 
Figure 2. (A) Scatter plot of NADH cell phasor FLIM in the cytoplasmic pool of the Httex1p25Q (N = 12, 
in blue) expressing cells compared to the Httex1p97Q cells in red (N = 18). EGFP control is plotted in green 
triangle (N = 15). Each point represents the average lifetime plotted in the phasor coordinates. Using image 
segmentation the cytoplasmic region for each cell is selected. Expanded cells (97Q) shows higher free to bound 
NADH ratio (shifted toward right). (B) Similar plot was obtained for individual cell nuclei of the Httex1p25Q 
cells compared to Httex1p97Q cells. Cells transfected with 97Q are further shifted towards the right side of the 
plot indicating an increase of free NADH in the nucleus.
Figure 3. Tiled images of ELAV GAL4 X UAS Httexon1p Q96-GFP Drosophila eye disc. Bright field image 
merged with FITC shown here (Scale bar on the image is 50 um).
www.nature.com/scientificreports/
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conflicting results can be due to sensitivity of sample preparation as well as average population or bulk measure-
ments. Thus, pursuing the quest to understand and learn about metabolic dysfunctions in a non-invasive manner 
and at the single cell level may elucidate the role of impaired metabolic pathways that can lead to transcriptional 
dysregulation in the disease.
Previous studies in animal models and HD patients reported perturbation of metabolism in HD in animal 
studies and HD patients. Several studies associate HD with Diabetes Mellitus as significant numbers of R6/2 mice 
develop diabetes gradually4,36. Other studies also reported that glucose metabolism can be an indicator of HD 
onset37,38.
Our present study, using 2P-FLIM, indicates a decrease in fluoresce lifetime of NADH that is correlated with 
an increased in free to bound ratio of NADH in HD. These changes indicate ATP production shifts from oxidative 
phosphorylation to glycolysis that can lead to an increase in oxidative stress and eventual cell death. Given that 
the lifetimes of NADH and Nicotinamide Adenine Dinucleotide Phosphate (NAD(P)H) are virtually indistin-
guishable, alternation of free to bound NAD(P)H could also reflect these changes. Our results are consistent with 
an earlier report by Valencia et al. showing elevated NADPH oxidase activity leading to over production of ROS 
and cell death in HD mice39.
Figure 4. Unexpanded ELAV-GAL4 X UASQ25 vs. expanded ELAV-GAL4 X UASQ120 expressing flies 
results are depicted here. NADH emission obtained with 740 nm two-photon excitation is shown under the 
intensity map. Lifetime color map of NADH is depicted on the right (color map). Shorter lifetime is color coded 
with red here while longer lifetime on the phasor plot is associated with cyan. As it is shown here Htt 120Q cells 
are characterized with a distinct population shifted toward shorter lifetime (red) that has a higher ratio of free 
to bound NADH. Panels C&D show the phasor plot for 25Q and 120 Q respectively. The phasor histogram is 
shifted toward the direction of free NADH (glycolysis) in the expanded form 120Q compared to unexpanded 
25Q. Scale bar is 10 um.
Figure 5. Scatter plot of the NADH phasor FLIM showing average g and s phasor values for each animals 
eye disc ROI (N) for total of 15 animals and a total of N = 149 ROI measurements. The blue diamond refers to 
25Q (N = 30), green diamond Venus control (N = 28), gray asterisk wildtype with no HTT (Canton-S, N = 32).
Tissue with expanded expression 120Q (N = 32, in red circle) and 96Q-EGFP (N = 27, in red triangles) indicates 
shortening of the lifetime towards the glycolytic state, shifted to the right.
www.nature.com/scientificreports/
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Here we were able to examine changes in the fluorescence lifetime of NADH indicating an increased glycolytic 
state in HD using Phasor FLIM approach. Earlier, Plotegher et al. showed shifts of NADH to shorter lifetime 
(toward the glycolytic state) in the presence of alpha-synuclein aggregates in Parkinson disease (in HEK293-aS)14. 
Similar results were also reported recently using 2P-FLIM by Sandeep et al. in a pc12 model of Parkinson dis-
ease40. More recently in a pilot study, Jentsch used FLIM based technology in opthalmology based setting to 
examine the alteration in retina of Alzheimer disease patients. In this study, dependence of the fluorescence 
lifetime imaging parameter on the severity of Alzheimer’s disease is reported41.
The real advantage of the powerful method that we have proposed here is that it can be applied in tissue and 
a pixel map of cellular metabolic alteration can be obtained. We foresee that such precise measurements using 
phasor-FLIM finger printing approach can help address some of the current issues in the literature.
Conclusions
The underlying mechanism that affects neurodegeneration in Huntington disease is still under investigation. 
Compelling evidence indicates that mitochondria may play an essential role that affects neurodegeneration in 
Huntington disease. In this work, we have measured metabolic perturbations in cells transfected with various 
glutamine repeats (expanded vs unexpanded) as well as in the transgenic Drosophila eye discs using FLIM cou-
pled with phasor analysis. We used the autofluorescence lifetime of NADH as an intrinsic biomarker for such 
measurements. Results obtained here indicate a shift toward a larger free/bound NADH ratio in the presence 
of the expanded Huntington repeat both in vitro in Human Embryonic Kidney (HEK 293) cells as well as in the 
Drosophila eye disc model of Huntington disease. Such a shift in the expanded model may indicate depletion 
of ATP production and an increase in oxidative stress that can eventually lead to cell death. In addition, nuclear 
FLIM analysis on expanded polyQ HTT exon1 expressing cells indicates increased free NADH which influ-
ences CtBP and Sirtuin activity in the nucleus43. We propose that such a shift toward increased free NADH in 
the nucleus indicates transcriptional dysregulation which is crucial in Huntington pathogenies.
This report fingerprints metabolic shifts from OXPHOS to glycolysis in HD cells. In addition, we show that 
there is an increase in free NADH in the nuclear compartment in HEK293 expressing the expanded form of the 
polyQ HTT exon1. This result may indicate a transcriptional dysregulation in the nucleus which is important to 
understand in HD studies and also for similar neurodegenerative disease such as Alzheimer’s, Parkinson, ALS, 
and etc. Further investigations need be done to understand if different stages of inclusion formation or inclusions 
themselves uniquely alter redox state of the cells.
Material and Methods
Cell cultures and transfection. Human Embryonic Kidney cell 293(HEK293) plated on 3 ug/ml fibronec-
tin were plated with ~70% confluency and transfected overnight with Httex1p containing pcDNA with varying 
length of polyglutamine fused at C-terminus to EGFP(Httex1p 97Q-EGFP, Httex1p25Q -EGFP, and EGFP alone).
Confocal Imaging. The EGFP tagged cells were visualized via confocal microscopy Zeiss LSM 710 confocal 
microscope (Carl Zeiss, Jena, Germany). Images are obtained with a 488 nm argon-ion laser and imaged using 
the internal detectors using a filter 500–550 nm. Using laser scanning confocal microscope, the fluorophore of the 
entire specimen were acquired and assigned a pseudo-color. Images are acquired using 63x oil objective.
FLIM set up. Fluorescence lifetime imaging were acquired using the same Zeiss LSM 710 confocal microscope 
equipped with Ti-Sapphire laser (Mai Tai Spectra-Physics, Newport, CA), using external detectors (H7422P-40, 
Hamamatsu Corporation, Bridgewater, New Jersey) and an ISS A320 FastFLIM unit (ISS, Champaign, IL). 
NADH fluorescence lifetime was measured upon 2–photon excitation at 740 nm. A 495 nm long-pass filter was 
used to separates the blue and the green fluorescence channel. NADH emission was detected with a blue filter 
(442/46 nm) in one channel and EGFP emission with a green filter (520/35 nm). Images were acquired using 63X 
Figure 6. Summary of the data analysis for live tissue of drosophila eye disc (expanded 96Q (N = 27), 120Q 
(N = 32), unexpanded 25Q (N = 30), and control (Venus, N = 28) are depicted here. Arrow bar shows the 
direction of Free NADH. Expanded Htt( both 96Q and 120Q) are characterized with significant increased ratio 
of free to bound NADH( more Glycolytic) compared to unexpanded Htt (25Q).
www.nature.com/scientificreports/
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oil objective. Images were collected with 256 × 256 pixels with a minimum of 100 counts per pixel which requires 
at least integrating 30 frames with a pixel dwell time of 25.6 us/pixel. The temperature was set at 37 °C throughout 
the experiment with 5% CO2.
Data analysis. The phasor analysis was performed using the method explained by Digman et al.42 and ana-
lyzed with the SimFCS software available at (www.lfd.uci.edu). Briefly, for each pixel in an image, a phasor lifetime 
is plotted in a graph using Fourier transformation, we then use a cursor to highlight the cluster of points that 
corresponded to the lifetime in that range. Figure S1 in supplemental material schematically shows the transfor-
mation process to a single point in a 2D phasor plot. Phasor plot coordinates are g and s (x and y).
Statistical analysis. We have used student’s t-test with critical p-value set at 0.05 for our analysis. Total of 
45 HEK293 cells have been tested for in vitro study of HD. For the animal study we have used total of 15 animals 
and analyzed N = 149 total regions of interests (ROI~30–50 μ m2 in the posterior area of the eye disc)) (N = 30 
for 25Q, N = 32 for 120Q, N = 27 for 96Q-EGFP, N = 28 for Venus, N = 32 for wildtype Canton-S). A total of 15 
animals which expressed HTT 25Q versus 120Q tagged to a fluorescent protein, Kaede. shows that tagging the 
protein does not perturb the NADH fluorescence lifetime changes observed in the unlabeled animals (figure S4). 
For the 120Q-Kaede we have analyzed N = 39 regions of interest of 8 animals imaged at the distal end of the eye 
disc in comparison with the 25Q-Kaede where N = 27 ROI of 7 animals were analyzed.
Animal Study. ELAV-GAL4 is used for expression of UAS transgene. Fly stocks were cultured on cornmeal 
medium at 25 degree (room temperature). Larvae at the late 3rd instar, instar refers to larvae stage, were selected and 
transferred into a petri dish with dissection buffer. Using forceps, the mouth hooks were pulled away from the rest 
of the body. The eye discs were dissected away from the rest of the tissue and immediately placed on a coverslip for 
imaging. In this experiment we have used Unexpanded 90ex1 25Q, expanded 90ex1 96Q-EGFP (a kind gift of T. Littleton), 
expanded 90ex1 120Q, and wild type, Canton-S, with no HTT transfection and Venus as controls. In addition we have 
verified our analysis by co-expressing Kaede expanded vs. unexpanded HTT(90ex1 25Q-Kaede vs. 90ex1 120Q-Kaede) to fur-
ther verify the NADH FLIM readings.
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